Identified a group of biomarkers in tear samples to improve early diagnosis of primary open angle glaucoma, contributing to the prevention of blindness.

The research entitled "Biochemical-molecular-genetic biomarkers in the tear film, aqueous humor, and blood of primary open-angle glaucoma patients" was carried out with the participation of Dr. Vicente Zanón Moreno, professor at the International University of Valencia - VIU and researcher at the Institute of Biosanitary Research of VIU (IIB-VIU). Also, Dr. Mª Dolores Pinazo Durán and Dr. Irene Andrés Blasco, collaborators of the research group in Clinical, Genetics, Epigenetics and Molecular Epidemiology (ECLIGEM) of the IIB-VIU have participated in this project.

Transplantation of umbilical cord mesenchymal stromal cells delays the onset of hyperglycemia in models of autoimmune diabetes

A groundbreaking study with the participation of Dr. Abdelkrim Hmadcha from IIB-VIU has shown that transplantation of umbilical cord mesenchymal stromal cells delays the onset of hyperglycemia in experimental models of autoimmune diabetes through multiple immunosuppressive and anti-inflammatory responses.

Dr. Maribel Marquina joins the Secretariat of the Biosanitary Research Institute of Valencian International University

La epigalocatequina 3-galato (EGCG), antioxidante presente en el té verde, clave para tratar alteraciones de la función cardíaca generadas por la exposición prenatal al alcohol

9 de Mayo de 2023. El Dr. Vicente Andreu Fernández y la Dra. Elisabet Navarro Tapia, investigadores del Instituto de Investigaciones Biosanitarias de VIU, han desarrollado en colaboración con el Grup de Recerca Infància i Entorn (GRIE) del Hospital Clínic de Barcelona el primer estudio que demuestra los beneficios de la epigalocatequina 3-galato (EGCG), un antioxidante natural derivado del té verde, para atenuar las afecciones cardíacas producidas a consecuencia de la exposición prenatal al alcohol.